Clinical trials
Patient Participation clinical trials
Below are recruiting patient participation clinical trials, each written for real people, not researchers. We’re tracking 84 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07559253Recruiting
Heart Care Transition Education Led by Nurses or Doctors
This study tests whether nurse-led or doctor-led education helps young people with congenital heart disease (a heart condition present from birth) transition from pediatric to adult care. The goal is to make this transition smoother and more accessible for all patients, including those with disabilities.
Madison, WisconsinAges 12–26 - NCT06930508Recruiting
Bringing HIV prevention meds to a family planning clinic
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
Providence, Rhode IslandAges 16 years+ - NCT06905119Recruiting
Smartphone app for managing PICC line care
This study tests a smartphone app to help manage care for people with a PICC (a long-term IV line). It aims to improve communication and monitoring during treatment at home.
Pamplona, NavarreAges 18 years+ - NCT06979102Enrolling by invitation
Stoma care teaching for new ileostomy patients and caregivers
This trial tests a teaching method that uses a real patient to help new ileostomy patients and their unpaid caregivers learn stoma care and management. It aims to improve confidence and skills.
Ankara, TurkeyAges 18 years+ - NCT07712939RecruitingPhase 1
Study of CND319 for rheumatic diseases
This study tests a new drug called CND319 in healthy volunteers and people with rheumatoid arthritis or Sjögren's disease. The goal is to see if it is safe and how the body responds to it.
Melbourne, VictoriaAges 18–65 - NCT06019455Recruiting
How patients participate in lung and esophageal cancer care
This study looks at how much patients with lung or esophageal cancer get involved in decisions about their care when they receive chemotherapy and radiation together. It aims to learn what helps or challenges patients in taking an active role.
GuangzhouAges 18–75 - NCT06337214Recruiting
TCM therapy for energy in breast cancer patients
This trial tests whether adding Traditional Chinese Medicine (TCM) therapy can help maintain or improve your energy and vitality while you are undergoing standard cancer treatments like chemotherapy, radiation, or targeted therapy.
TaipeiAges 18–85 - NCT06322264Recruiting
Helping children take part in X-ray exams
This study tests a new method to help children aged 4 to 12 feel more involved and comfortable during standard X-rays. It may make the experience easier for kids, parents, and radiographers.
Lund, Skåne CountyAges 4–12 - NCT06751641Recruiting
Survey about your experience in a drug trial
This survey asks adults (patients or healthy volunteers) who are in a drug trial about their experience—especially if the trial lets them get treatment at home or at the study site. Your answers will help make future trials easier for patients.
NantesAges 18 years+ - NCT05632120Enrolling by invitation
Testing how COPD affects daily movement and participation
This study looks at how chronic obstructive pulmonary disease (COPD) may affect your body function, walking, and ability to take part in everyday life. It may help researchers understand what support or therapies could improve daily activities.
Istanbul, Fatih/İstanbulAges 35–80 - NCT06934252RecruitingPhase 1
Study of TRB-061 for atopic dermatitis (eczema)
This trial tests an investigational drug called TRB-061 in healthy adults and people with atopic dermatitis (eczema). It aims to see if the drug is safe and how the body processes it. If you have moderate to severe eczema that started at least a year ago, you may be able to join the patient part of the study.
Belconnen, Australian Capital TerritoryAges 18–70 - NCT04657783Recruiting
French cohort study of people with type 1 diabetes
This study follows people with type 1 diabetes in France to better understand the condition over time. It may help researchers improve future care, especially for how type 1 diabetes starts and is managed from early diagnosis onward.
ParisAges 6–100 - NCT06704048Recruiting
Heart rehab after endocarditis: quality of life study
This study looks at how a heart rehabilitation program affects quality of life and personal experiences in people who have been treated for infective endocarditis (a serious heart infection). It aims to find out if this type of rehab helps patients feel better and recover more fully.
Halmstad, Halland CountyAges 18–90 - NCT06722352Recruiting
Palliative care education for dementia in assisted living
This study trains staff in assisted living facilities to better support residents with dementia and their families in planning future care. It focuses on helping families talk about advance care planning (decisions about future medical care) with the care team.
Tampa, FloridaAges 21 years+ - NCT07669168Recruiting
Health study comparing usual care vs. extra support
This study looks at whether adding extra health support helps people stay healthier over time. You would be followed for a while and asked to share how you are doing.
Boulder, ColoradoAges 18 years+ - NCT07283627Enrolling by invitation
Mind-body therapies for cancer patients' quality of life
This trial studies how mind-body therapies like meditation or yoga affect your quality of life and emotional well-being during cancer treatment. You need to have already completed one of these therapies to take part.
Meyrin, Canton of GenevaAges 18 years+ - NCT06478628Enrolling by invitation
Insomnia in pain rehabilitation patients
This trial looks at sleep problems in people going through pain rehabilitation. It aims to understand and possibly improve sleep in those with long-lasting pain.
RissaAges 18 years+ - NCT05049668Enrolling by invitation
Long-term follow-up for people from the RACE study
This study checks on people who took part in the earlier RACE trial and collected long-term health information. It helps researchers understand how the treatments given in that trial affect patients over time.
ParisAges Any age - NCT07415031RecruitingPhase 2
Long term treatment with adagrasib for solid tumor patients
This trial allows people with solid tumors who are already benefiting from the study drug adagrasib in an earlier Mirati study to continue getting it for the long term. It’s for people whose doctors see ongoing benefit and who still meet the safety rules.
Phoenix, ArizonaAges 18 years+ - NCT07412691RecruitingPhase 1
Safety study of BG-A3004 in healthy people and skin disease patients
This study tests a new drug (BG-A3004) for safety in healthy volunteers and people with certain skin conditions like alopecia areata, cutaneous lichen planus, or vitiligo. It helps find out if the drug is safe and how the body processes it.
Beijing, Beijing MunicipalityAges 18–60 - NCT06564389RecruitingPhase 1
First-in-human study of PF-07832837 in healthy adults and eczema patients
This trial is testing a new investigational medicine (PF-07832837) for safety in healthy adults and in people with moderate to severe atopic dermatitis (eczema). It is a first-in-human study, so it looks at how well the body tolerates the medicine.
Anaheim, CaliforniaAges 18–70 - NCT06546670RecruitingPhase 1/Phase 2
Study of ITU512 for sickle cell disease
This trial tests a new medicine called ITU512 in two groups: healthy volunteers and people with sickle cell disease. In the second part, researchers want to see if ITU512 can help manage sickle cell disease.
Birmingham, AlabamaAges 12–55 - NCT06135350RecruitingPhase 2
Preventing infections in ICU patients on ventilators
This trial tests an experimental drug called Fluorothiazinone to prevent serious bacterial infections in ICU patients who are on a breathing machine (ventilator) or likely to need one soon. It includes patients with COVID-19 pneumonia, stroke, or heart failure.
Moscow, MoscowAges 18 years+ - NCT07014865Recruiting
Quality of life and social participation in multiple myeloma patients and caregivers
This study looks at how multiple myeloma and its treatment affect the daily life, well-being, and social activities of patients and their caregivers. It aims to understand what factors influence their quality of life.
Reggio Emilia, REAges 18 years+
Hear when a new Patient Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient participation?
- Yes. Clin2 currently lists 84 recruiting patient participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.